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Abstract
Pseudoxanthoma elasticum (PXE) is a genetic connective tissue disease, whose gene and pathogenesis are still unknown.
Dermal fibroblasts from patients affected by PXE have been compared in vitro with fibroblasts taken from sex and age-
matched normal individuals. Cells were grown and investigated in monolayer, into three-dimensional collagen gels and in
suspension. Compared with normal cells, PXE fibroblasts cultured in monolayer entered more rapidly within the S phase and
exhibited an increased proliferation index; on the contrary, similarly to normal fibroblasts, PXE cells did not grow in
suspension. Furthermore, compared with normal fibroblasts, PXE cells exhibited lower efficiency in retracting collagen type
I lattices and lower adhesion properties to collagen type I and to plasma fibronectin. This behavior was associated with
higher expression of integrin subunits K2, K5, Kv, whereas L1 subunit as well as K2L1 and K5L1 integrin expression was lower
than in controls. Compared to controls, PXE fibroblasts had higher CAM protein expression in accordance with their high
tendency to form cellular aggregates, when kept in suspension. The demonstration that PXE fibroblasts have altered cell-cell
and cell-matrix interactions, associated with modified proliferation capabilities, is consistent with the hypothesis that the
gene responsible for PXE might have a broad regulatory role on the cellular machinery. ß 2000 Elsevier Science B.V. All
rights reserved.
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1. Introduction
Pseudoxanthoma elasticum (PXE) is an inherited
connective tissue disorder mainly characterized by
time-dependent mineralization of elastic ¢bers [1^3].
The most evident clinical manifestations are repre-
sented by white-yellow papules and redundant ridges
in the skin, especially at the £exural areas, angioid
streaks around the macula which may progress lead-
ing to retinal hemorrhages and visual loss. However,
mineralization up to occlusion and hemorrhages has
been described in vessels of almost all organs [4].
PXE has been recognized for decades as an elastic
¢ber disorder, however polymorphism, fragmenta-
tion and mineralization of the elastic component
are not the only pathological manifestations in the
dermis of PXE subjects. Abnormal masses of thread
material containing proteoglycans and a series of
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other matrix molecules [5^7] as well as collagen ¢bril
abnormalities have been frequently observed in the
a¡ected dermis of these patients [6]. The recent ob-
servations that the PXE gene is localized into the
region p13.1 of chromosome 16 [8,9], even though
the gene and its product are still unknown, clearly
indicate that elastin, whose gene is on chromosome 7
[10], is not primarily involved. Therefore, elastin
mineralization as well as collagen and proteoglycan
alterations may represent secondary events of a cell
derangement whose comprehension may help in
understanding the pathogenesis of clinical manifesta-
tions.
Up to now, very little attention has been paid to
PXE ¢broblasts in vivo as well as in vitro. It has
been observed that in the a¡ected dermis ¢broblasts
are numerous, large, polymorphic with dilated cister-
nae of the endoplasmic reticulum [6,11]. Moreover,
tissue samples in vitro have been show to incorporate
labeled amino acids into proteins with higher e⁄-
ciency than normal skin [12]. When cultured in vitro,
PXE dermal ¢broblasts grow very actively and have
been shown to have higher synthetic capabilities for
collagen and elastin [12], to exhibit abnormal serine
protease activity [13] and altered proteoglycan me-
tabolism [11,14]. Actually, PXE ¢broblasts produce
families of proteoglycans with higher molecular
weights compared to controls [11] and which di¡er
from controls also for their sulfation characteristic
[14]. Moreover, preliminary results, on in vitro cul-
tured cells, seem to indicate that PXE ¢broblasts are
characterized by peculiar cytoskeletal structures, con-
sistent with the hypothesis of altered cell-matrix in-
teractions [15].
Since cell-matrix interactions play a crucial role in
the control of gene expression, thus regulating cell
survival, growth, di¡erentiation, motility and syn-
thetic capability [16,17], aim of the present investiga-
tion was to perform in vitro studies for a better
characterization of ¢broblasts from clinically a¡ected
and una¡ected dermis of PXE patients, in compar-
ison with ¢broblasts derived from sex and age-
matched healthy subjects, mainly focusing on cell-
matrix interactions and proliferation capabilities.
2. Methods
2.1. Cells and tissues
Dermal biopsies from the neck or the armpit were
obtained after informed and signed consent from ¢ve
control women (age 39 þ 6 y) and from ¢ve women
a¡ected by PXE (age 43 þ 2 y). In two patients,
punch biopsies were taken from both a¡ected and
una¡ected areas. From each bioptic sample, ¢bro-
blast cultures were established and small fragments
were ¢xed and embedded for electron microscopy in
order to have always a morphologic assessment of
the cellular and extracellular compartments in situ.
2.2. Cell cultures
Cells, unless otherwise speci¢ed, were grown in
monolayer in Dulbecco’s modi¢ed Eagle’s medium
(DMEM) plus antibiotics in 25 cm2 £asks (Nunc,
Roskilde, Denmark) and were used between the third
and the eight passage.
Synchronized cells were obtained by 12 day incu-
bation of nearly con£uent cells in DMEM plus 1%
FCS [18] and the G0 phase was checked by £ow cy-
tometry.
For suspension cultures, freshly trypsinized ¢bro-
blasts were plated on a polymerized agarose gel type
VII (0.9% in DMEM-F12 or DMEM) in 100 mm
Petri dishes for bacteriology; 1U106 cells in 10 ml
of DMEM-F12 or DMEM containing 15 mM
HEPES pH 7.4, 1 mg/ml crystalline BSA, 25 nM
sodium selenite, 5 Wg/ml human transferrin, 10 Wg/
ml bovine insulin [19] were added to each plate.
2.3. Cell growth
In order to obtain the growth curve, 1.2U104 cells
were cultured in monolayer into 35 mm Petri dishes
(Nunc) in 2 ml DMEM plus 10% FCS. After 1, 2, 3
and 4 days of culture, cells were trypsinized, centri-
fuged and resuspended in a small amount of me-
dium. Aliquots of this suspension were used to assess
the cell number by mean of the Neubauer chamber.
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The duplication time (DT) was calculated using
the following formula:
DT  48 : log2 cell number after 48 h3
log2 cell number at time 0
To assess thymidine incorporation, 120 000 cells
were plated in 35 mm Petri dishes and cultured for
1, 2, 3 and 5 days. At each time point, 10 Wl of
[3H]thymidine (1 mCi/ml) were added to the medium
and after 3 h incubation at 37‡C, the medium was
removed and the monolayer washed twice with cold
HBSS, 5% trichloroacetic acid (TCA) and absolute
ethanol. The monolayer was air dried and then
treated with 0.3 N NaOH for 10 h at room temper-
ature. 0.5 ml of the cellular suspension was placed in
scintillation vials, added with 1.5 N HCl and scintil-
lation mixture (Ready gel, Beckman). Radioactivity
was measured in a Beckman LS1701 scintillation
counter. Experiments were done in triplicate.
2.4. Cell cycle
For the analysis of the cell cycle in monolayer,
nearly con£uent cells (3U105 cells in a 25 cm £ask)
were synchronized in G0 by 12 days incubation of
nearly con£uent cells in 7 ml of DMEM plus 1%
FCS, as described above [18]. After assessment of
the G0 state by £ow cytometry, cells were induced
to enter in the S phase by replacement of the medium
with DMEM plus 20% FCS. After 4, 12, 18, 24, 30,
42 and 48 h culture, the cell cycle was assayed by
incubation with 10 WM bromodeossiuridine (BrdU)
for 30 min at 37‡C; cells were then trypsinized, sus-
pended in DMEM, treated with 0.5% Tween 20
(Merck) centrifuged at 2000 rpm for 5 min, resus-
pended in 0.5 ml 0.5% Tween 20 in PBS and in
0.5 ml 4 N HCl and incubated for 30 min at room
temperature. After centrifugation, cells were sus-
pended in 1 ml 0.1 M Borax (Riedel-de Haen), cen-
trifuged, incubated for 1 h at 4‡C in 200 Wl 0.5%
Tween 20 in PBS containing 5 Wl anti-BrdU mono-
clonal antibody (Becton Dickinson, USA), centri-
fuged, incubated for 30 min at 4‡C in 200 Wl 0.5%
Tween 20 in PBS and 5 Wl of £uorescein isothiocya-
nate (FITC)-labeled goat anti-mouse immunoglobu-
lins (Becton Dickinson, USA), centrifuged, incubated
for 15^30 min at 4‡C in 200 Wl 0.5% Tween 20 in
PBS and in 200 Wl propidium iodide (Sigma) and
¢nally analyzed on a £uorescence activated cell sorter
FACScan (Becton Dickinson, USA).
For the analysis of the cell cycle in suspension,
cells were synchronized in G0 by 3 day-incubation
of early con£uent cells (1U106 cells in 75 cm £ask)
in 15 ml of de¢ned medium as speci¢ed above [19].
Brie£y, after assessment of the G0 state by £ow cy-
tometry cells were trypsinized and plated on a poly-
merized agarose gel in 100 mm Petri dishes in the
presence of DMEM or DMEM-F12, 1 mg/ml crys-
talline BSA, 25 nM sodium selenite, 5 Wg/ml human
transferrin, 10 Wg/ml bovine insulin, 5% FCS and
3 nM EGF [19]. After 18 and 24 h the cell cycle
was assessed, as described above for cells in mono-
layer.
2.5. Cell-cell and cell-matrix interactions
2.5.1. Adhesion and spreading assay
Plastic Petri dishes (35 mm in diameter) uncoated
or coated with collagen type I (Nunc) or plasma
¢bronectin (Nunc) were used. Trypsinized cells
were washed in serum free DMEM, centrifuged
and 1U105 cells in 1 ml suspension were added to
each dish and allowed to attach by setting for 10 min,
20 min, 40 min, 1 h, 4 h up to 24 h at 37‡C in 5%
CO2/95% air. Adhesion was evaluated as previously
described [20]. Brie£y, at each time considered, non
adherent cells were removed by washes with PBS,
whereas adherent cells were ¢xed with 3% parafor-
maldehyde for 10 min, washed with PBS twice,
stained with crystal violet (0.5% in 20% methanol)
for 15 min and extensively washed with distilled
water. Color retained by cells was eluted by 0.1 M
sodium citrate for 30 min at room temperature, read
in a spectrophotometer at 540 nm, and considered
proportional to the number of adherent cells. Cell
spreading was evaluated with a phase contrast light
microscope (Zeiss axiophot) after 4 and 24 h from
seeding. All experiments were performed in triplicate.
2.5.2. Collagen gel retraction
Collagen gels were prepared by using both Vitro-
gen collagen solution (Celtrix) or collagen extracted
from rat tail tendons in 0.1% acetic acid as previ-
ously described [20]. Collagen solutions were neutral-
ized by adding 0.1 M NaOH and brought to the
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concentration of 2 mg protein/ml. Cells were added
at a concentration of 1U105 cells/ml. Aliquots (2 ml)
of the cell/collagen mixture were placed in 35 mm
diameter Petri dishes and allowed to polymerize at
37‡C for 15^20 min. To create £oating collagen gels,
the edge of lattices was rimmed with a sterile pipette
and the dishes were gently shaken. Floating gels were
covered with 2 ml of DMEM with 10% fetal calf
serum. Experiments were done in triplicate and the
retraction was evaluated every 12 h during a 3 day
period by measuring the gel area on a millimetric
scale [21].
2.5.3. Expression of adhesion molecules
In order to investigate integrin expression, cells at
con£uence were removed from tissue culture £asks
with 10 ml ethylenediaminetetraacetic acid (EDTA)
(10 mM in PBS3, without calcium and magnesium)
at 37‡C. EDTA was blocked by addition of the same
amount of PBS with 10 WM calcium and 10 WM
magnesium. Cells were washed twice with PBS3
and resuspended to 5U105 cells in 200 Wl PBS3
and incubated for 30 min at 4‡C with 5 Wl of undi-
luted monoclonal antibodies against K1 (Chemicon,
Temecula, USA), K2 (GIBCO BRL), K5 (GIBCO
BRL), Kv (GIBCO BRL) and L1 (GIBCO BRL) sub-
units of human integrin or against integrins K2L1
(Chemicon) and K5L1 (Chemicon) or against A-cell
adhesion molecules (CAM) proteins (Sigma). After a
rapid centrifugation cells were incubated for 30 min
at 4‡C with FITC-labeled anti mouse-immunoglobu-
lins (Dako, Denmark; 1:10 diluted). Controls were
established by using the secondary antibody alone or
non-immune idiotypic immunoglobulins. Washed
cells were resuspended in 250 Wl of PBS3 and ana-
lyzed on a FACScan (Becton Dickinson, USA). De-
bris and dead cells were excluded by forward and
side scatter gating. Ten thousand events were col-
lected and evaluated from each cell type using Lysyl
II Software.
2.6. Structure
2.6.1. Cell dimension
Cells grown for 48 h at con£uence on 35 mm Petri
dishes were trypsinized, centrifuged, washed with
DMEM, centrifuged again and resuspended in
DMEM. Glutaraldehyde was added to the ¢nal con-
centration of 1% and ¢xation was performed for 30
min. After staining with 1% toluidine blue, aliquots
of cells were spread on coverslips and observed by a
light microscope connected with an image analyzer
equipped with a program for registration of the cell
volume. About 1000 cells were examined for each
control and PXE subject.
2.6.2. Cell morphology
Cells, grown on glass or on plastic surfaces coated
or not with collagen or ¢bronectin, were: (a) ¢xed
with 3% paraformaldehyde in PBS for 30 min at 4‡C
and observed either unstained or after staining with
hematoxylin eosin or crystal violet, by a Zeiss axio-
phot optical microscope in the phase contrast mode
(b) ¢xed with 3% paraformaldehyde in PBS for 30
min at 4‡C, permeabilized by incubation for 5 min in
serum-free DMEM and 1% Triton X-100, treated
with FITC-labeled falloidin (2 Wg/ml) for 15 min at
room temperature and observed by a confocal micro-
scope (c) ¢xed with 2.5% glutaraldehyde in Tyrode’s
solution, dehydrated, embedded in Spurr resin, sec-
tioned and observed in a Siemens 1A and a Jeol
1200EXII transmission electron microscope.
Cells, grown into collagen gels or in suspension on
agarose, were (a) observed and photographed with
an Olympus inverted microscope (b) ¢xed in 2.5%
glutaraldehyde in Tyrode’s Solution, dehydrated, em-
bedded in Spurr, sectioned and observed with a Sie-
mens 1A and a Jeol 1200EXII transmission electron
microscope.
3. Results
3.1. Cell growth
PXE and control ¢broblasts were examined up to
the eight passages in monolayer and exhibited good
growth capabilities. Fig. 1 shows the growth curve of
synchronized normal and PXE cells: ¢broblasts from
PXE patients grew faster between the second and the
fourth day of culture, then, at con£uence, all cells
showed the same growing rate. Cells from una¡ected
areas of PXE patients behaved in between of control
and diseased cells.
In accordance, the duplication time of PXE ¢bro-
blasts (n = 5) was about 20% shorter than in controls
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(n = 5) grown in parallel (30.5 vs. 38.7 h of control
cells ; P6 0.003, by Student’s t-test performed on re-
sults from experiments repeated three times), and
cells from una¡ected areas of patients had a dupli-
cation time in between.
Interestingly, after 24 h culture [3H]thymidine in-
corporation was lower in diseased ¢broblasts com-
pared to control cells (Fig. 2). These data can be
better understood from the analysis of the cell cycle
between 12 and 24 h of culture. No signi¢cant di¡er-
ences were noted between ¢broblasts from clinically
a¡ected or una¡ected areas of patients.
3.2. Cell cycle
For this purpose, nearly con£uent cells were
synchronized by 12 days incubation in low serum
medium, as described in Section 2. Four hours after
addition of high serum concentration, PXE ¢bro-
blasts were still in the G0 phase, whereas 3% of con-
trol cells were in the S phase (Fig. 3). From 12 to 24
h both control and PXE cells entered the S phase,
being the number of PXE cells always higher than
that of controls. After 24 h, 26% of diseased ¢bro-
blasts were in the S phase compared with the 9% of
control cells (Fig. 3). Thirty hours after addition of
high serum concentration, 17 and 14% of PXE and
control cells respectively were in the G2/M phase
(Fig. 3). After 48 h almost all cells were again in
the G0 phase (Fig. 3).
As expected for dermal ¢broblasts, both control
and PXE cells remained in the G0 phase and never
entered the S phase when grown in suspension (data
not shown).
3.3. Adhesion
Normal dermal ¢broblasts showed a discrete adhe-
sion capability onto plastic uncoated dishes, whereas
they appeared to adhere very e⁄ciently onto plasma
¢bronectin and collagen type I coated dishes. By
contrast, PXE ¢broblasts exhibited at all times lower
attachment properties to uncoated dishes
(P6 0.001), to collagen type I (P6 0.0001) and to
¢bronectin (P6 0.001) (Fig. 4). Interestingly, cells
from the una¡ected dermis of PXE patients exhibited
a behavior that was between normal and diseased
cells (Fig. 4).
3.4. Collagen gel retraction
Cell-matrix interactions were also investigated by
Fig. 1. Cell growth measured by means of a Neubauer cham-
ber. Fibroblasts from PXE patients, from both clinically af-
fected (PXEp, n = 5) or una¡ected (PXEn, n = 2) areas, grow
faster than control cells (C, n = 5). Experiments have been per-
formed three times in triplicate.
Fig. 2. [3H]Thymidine incorporation of cultured dermal ¢bro-
blasts. PXE ¢broblasts from both clinically a¡ected (PXEp,
n = 5) or una¡ected (PXEn, n = 2) areas show reduced levels of
incorporation compared to ¢broblasts from healthy subjects (C,
n = 5), in accordance with the observation that, after the ¢rst 24
h of culture, pathologic ¢broblasts already had incorporated
the radioactive thymidine. Experiments have been performed
three times in triplicate.
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growing cells into £oating collagen matrices made of
either Vitrogen or collagen extracted from rat tail
tendons and by measuring the lattice retraction
with time up to 3 days. PXE ¢broblasts were signi¢-
cantly less e⁄cient than normal cells in retracting
collagen gels at all times investigated, becoming the
di¡erence mostly evident after the ¢rst 24 h of cul-
ture (Fig. 5, P6 0.05).
3.5. Cell-cell and cell-matrix adhesion molecules
The integrin pattern of normal and diseased ¢bro-
Fig. 3. Cell cycle evaluated by FACS analysis in control (C, n = 5) and PXE (PXE, n = 5) ¢broblasts. Numerous pathologic cells enter
more rapidly in the S phase, between 12 and 24 h, in agreement with data from cell growth and [3H]thymidine incorporation. Experi-
ments have been performed four times.
Fig. 4. Adhesion of control (C, n = 5) and PXE ¢broblasts, from both clinically a¡ected (PXEp, n = 5) or una¡ected (PXEn, n = 2)
areas, on untreated plastic dishes for bacteriology, or collagen type I- and ¢bronectin-coated Petri dishes. On all substrates PXE cells
adhere less e⁄ciently compared to control ¢broblasts. Data are expressed as percent of attached cells compared to the highest values
of optical density obtained in control cells plated for 24 h on to ¢bronectin taken as 100. Experiments have been performed three
times in triplicate.
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blasts was investigated by FACS analysis on
synchronized cells grown in monolayer at con£uence.
As illustrated in Fig. 6, PXE ¢broblasts, compared to
normal cells, exhibited a reduced expression of K1
and L1 (P6 0.05) integrin chains and of dimers
K2L1 (P6 0.05) and K5L1. By contrast, pathologic
cells showed higher expression of K2 (P6 0.01), K5
(P6 0.01) and Kv chains, compared to control cells.
The presence of CAM proteins was investigated by
FACS analysis on synchronized cells grown in mono-
layer as well as in suspension. No signi¢cant di¡er-
ences between normal and PXE ¢broblasts were seen
when cells were grown in monolayer (Fig. 7); by
contrast, when cells were kept in suspension, a sig-
ni¢cant increase of the CAM protein expression was
observed in PXE ¢broblasts compared to controls
(Fig. 7, P6 0.05).
3.6. Morphology
The mean cell volume, as measured by an image
analyzer on cells detached from the growing sub-
strate and ¢xed in suspension, was 789 þ 160 Wm3
and 1191 þ 183 Wm3 for control (n = 4) and PXE der-
mal ¢broblasts (n = 5), respectively (P6 0.05, by Stu-
dent’s t-test performed on results from experiments
repeated four times).
By light microscopy, control dermal ¢broblasts,
grown at con£uence on glass slides in standard con-
ditions, exhibited a typical elongated shape with fre-
quent intercellular connections. At ultrastructural
level, abundant ribosomes and a well-developed en-
doplasmic reticulum were observed (data not shown).
Dermal ¢broblasts from PXE patients appeared
more polymorphous and larger than controls, with
exuberant cytoplasm. By electron microscopy, PXE
cells exhibited numerous mitochondria, huge and di-
lated cisternae of the endoplasmic reticulum (data
not shown). Moreover, in long term cultures, up to
9 days, both control and PXE cells were surrounded
by an extracellular matrix that was always more
abundant in PXE than in control cells [11].
When seeded on bacteriological dishes normal ¢-
broblasts adhere quite rapidly, although remaining
elongated and stretched out, whereas on matrix sub-
strates they appeared more numerous and expanded.
PXE ¢broblasts spread less e⁄ciently on all tested
substrates, being more globular with thin cytoplas-
mic projections (data not shown). After 24 h, control
¢broblasts on bacteriological dishes were still elon-
gated with thin cytoplasmic extrusions (Fig. 8A); by
contrast, when seeded on collagen type I or on ¢bro-
nectin they appeared well spread and had a distended
Fig. 5. Collagen gel retraction by control (C, n = 3) and PXE
(n = 5) ¢broblasts. Pathologic cells exhibited a reduced contrac-
tion of the gels suggesting the presence of altered cell-matrix in-
teractions. Experiments have been performed two times in trip-
licate.
Fig. 6. Integrin expression by FACS analysis in control (C,
n = 5) and PXE (n = 5) ¢broblasts. Pathologic cells exhibited
high expression of the K2, K5 and Kv subunit, but low expres-
sion of the K1 and L1 subunit and of the K2L1 and K5L1
dimers. Data are represented as percentage variation of values
obtained for each integrin in normal dermal ¢broblasts that
were always considered as 100. *P6 0.05; **P6 0.01 by Stu-
dent’s t-test. Experiments have been performed four times.
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polyhedric shape (Fig. 8B,C). Fibroblasts from af-
fected dermis of PXE patients spread less e⁄ciently
than control ¢broblasts on all substrates (Fig.
8D,E,F). PXE cells, in facts, appeared sometimes
shrunken, even on collagen type I and ¢bronectin
substrates, and were frequently connected by long
and thin cytoplasmic projections (Fig. 8E,F). The
actin cytoskeleton, visualized by falloidin, was
much less ordered in PXE ¢broblasts compared to
controls on all substrates (data not shown). Fibro-
blasts from una¡ected areas of the dermis from PXE
patients behaved in between of control and diseased
cells (data not shown).
When grown into three-dimensional collagen gels
control and PXE cells did not exhibit di¡erences re-
garding their morphology; they were polymorphous
and spread in all space directions (data not shown).
When grown in suspension on the agarose gel,
both control (n = 5) and PXE cells (n = 5) were round
and isolated one from the other up to 1 h of culture
(Fig. 9A); with time, a relatively low number of cells
from control subjects formed aggregates that after 24
h of culture exhibited an area of 1047 þ 392 Wm2
(Fig. 9B). By contrast, the great majority of PXE
¢broblasts, after the same period of time, formed
large polymorphic aggregates (1786 þ 555 Wm2 ;
P6 0.001 PXE vs. control, by Student’s t-test on
results from experiments repeated three times) (Fig.
9C). By electron microscopy, these aggregates ap-
peared as clusters of round cells (Fig. 9D). Cells
forming large aggregates were tightly packed and
their plasma membranes were in close contact for
long tracts (Fig. 9D, insert).
4. Discussion
PXE is a genetic connective tissue disorder, whose
gene and pathogenesis are still unknown [4]. Patients
are characterized by a progressive mineralization of
elastic ¢bers, although biochemical and structural
alterations of several other connective tissue compo-
nents have been demonstrated in all cases investi-
gated [5,6]. The accumulation in the extracellular
space of aggregates of electrondense thread material
containing glycosaminoglycans [5,7] as well as the
presence of structural alterations of collagen ¢brils
[6] suggest a more general involvement of connective
tissue metabolism, apart from elastin, in the patho-
genesis of PXE [6,7].
Up to now, only few studies have been performed
on in vitro cultured ¢broblasts. There are reports
that PXE ¢broblasts in vitro exhibit high proteolytic
activity, mainly due to the secretion of serine pro-
teases into the culture medium [13]. Biochemical
analysis showed that cells from the PXE-a¡ected pa-
tients produced a proteoglycan (PG) population with
stronger polyanionic properties, as well as a mark-
edly increased amount of high hydrodynamic-size
PGs [11]. In agreement with biochemical ¢ndings,
the immunohistochemical analysis showed altera-
tions a¡ecting PG content and distribution in PXE-
a¡ected cell layers [11,14]. Furthermore, preliminary
studies from our laboratory showed abnormal cyto-
skeletal organization in PXE ¢broblasts which might
be suggestive for altered cell-matrix interactions [15].
The present study was designed to characterize,
from both structural and behavioral points of view,
in vitro dermal ¢broblasts from patients a¡ected by
Pseudoxanthoma elasticum (PXE), paying particular
attention to cell-matrix interactions and to prolifer-
ation capabilities [22].
Fig. 7. CAM expression by FACS analysis on cells grown in
monolayer and in suspension. A signi¢cant increase of CAM
expression was observed in PXE cells (n = 4) grown in suspen-
sion compared to control cells (C, n = 4). Data are represented
as percentage variation of values obtained in normal dermal ¢-
broblasts that were always considered as 100. *P6 0.05 by Stu-
dent’s t-test. Experiments have been performed three times.
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Pathologic cells, grown in monolayer, were mor-
phologically di¡erent from normal dermal ¢broblasts
and these di¡erences were even more pronounced
when cells were seeded on, or within, extracellular
matrix substrates, such as collagen type I and ¢bro-
nectin, suggesting that PXE ¢broblasts might have
altered cell-matrix interactions. During the ¢rst
hour after seeding, as expected, normal dermal ¢bro-
blasts showed a rapid spreading on plastic, and es-
pecially on collagen type I or on ¢bronectin [23]. On
the contrary, PXE cells remained more globular,
spreading less e⁄ciently than normal ¢broblasts. Dif-
ferences in cell shape were still clear after 24 h after
seeding. These observations were con¢rmed in the
adhesion tests, where, as expected [23], normal der-
mal ¢broblasts showed high adhesiveness to collagen
type I and ¢bronectin, the two major components of
the extracellular matrix, whereas, in the same exper-
imental conditions, PXE ¢broblasts revealed signi¢-
cantly reduced adhesive capabilities.
These data have been further reinforced by experi-
ments in which cells were grown into three-dimen-
sional matrices of Vitrogen or of collagen extracted
from rat tail tendons [24,25]. PXE ¢broblasts exhib-
ited a signi¢cantly lower retraction capability com-
pared with normal cells and this may suggest scarce
Fig. 8. Spreading capabilities of control (A,B,C) and PXE ¢broblasts (D,E,F) on untreated plastic (A,D), or on collagen type I (B,E)
or fribronectin-coated (C,F) Petri dishes after 24 h from seeding. PXE ¢broblasts are generally less spread compared to control cells.
Bar: 10 Wm
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cell-collagen interactions or scarce capability of cells
to exert dynamic forces [26].
The indication that cell-matrix interactions may be
altered in PXE cells has been at least partially ex-
plained by FACS analysis of integrins. PXE cells
exhibited a signi¢cantly lower expression of the L1
chain or of the dimers K2L1 and K5L1 compared to
controls. As the L1 chain is involved in a series of
integrin dimers in combination with di¡erent K
chains, and dimers K2L1 and K5L1 are mainly re-
sponsible for interactions of cells with collagen and
with ¢bronectin [27], a signi¢cant lower expression of
these molecules clearly indicates that PXE cells have
scarce interactions with at least two of the main ex-
tracellular components that are involved in cell at-
tachment and may explain their scarce adhesion
properties and less e⁄cient collagen gel retraction.
Interestingly, the expression of K2 and K5 integrin
subunits was signi¢cantly higher in PXE ¢broblasts
compared with normal cells, and di¡erences,
although not signi¢cant, were also observed regard-
ing the K1 and Kv chains. These data seem to suggest
a deregulation in the synthesis, maturation and/or
assembly of a number of integrins in PXE ¢broblasts
and this point should be further investigated by con-
sidering the importance of cell-matrix interactions in
cell growth, di¡erentiation and metabolism [27,28].
Little is known concerning the factors modulating
the anchorage-dependent growth of dermal ¢bro-
blasts [29]. Integrins and matrix molecules seem to
play a crucial role in this context, since proliferation
of normal ¢broblasts can be blocked by growing the
cells in suspension on agarose [19] ; by contrast, a
number of other cells, such as cancer cells or chon-
Fig. 9. Control (A) and PXE ¢broblasts (B^D) grown in suspension and observed by light (A^C) and electron (D) microscopy. After
1 h from seeding on agarose type VII, control cells (A) as well as pathologic ¢broblasts are round and isolated one from the other.
After 24 h from seeding, pathologic cells (C) form aggregates bigger than control ¢broblasts (B), in accordance with the presence of
increased cell-cell interactions. At the ultrastructural level, these aggregates are comprised of cells (D) whose plasma membranes are in
close apposition (D, insert). Bar: 100 Wm (A^C) and 1 Wm (D).
BBADIS 61925 10-3-00
D. Quaglino Jr. et al. / Biochimica et Biophysica Acta 1501 (2000) 51^6260
drocytes, may grow and di¡erentiate in suspension
[30,31]. When kept in suspension, PXE dermal cells
behaved as normal dermal ¢broblasts, as they did
not enter the S phase. Interestingly, both normal
and PXE ¢broblasts, when kept in suspension,
tended to form aggregates, however, diseased ¢bro-
blasts exhibited a higher tendency to aggregate com-
pared to controls. This phenomenon can be ex-
plained by the higher expression of CAM proteins
on PXE ¢broblasts and is suggestive for decreased
cell-matrix interactions associated with increased
cell-cell adhesion properties.
When grown in monolayer, ¢broblasts from PXE
patients showed increased proliferation, as suggested
by the decreased duplication time, the increased
number of cells entering the S-phase and by lower
incorporation of thymidine by PXE ¢broblasts at 24
h, since at this time a great number of PXE cells was
already in the S phase. It is already known that in-
tegrin-mediated cell adhesion to matrix substrates
provides signals necessary for cell cycle progression
and di¡erentiation [32]. Moreover, it has been shown
that the K5L1 integrin modulates cell growth and
regulates gene expression [33]. In particular, disrup-
tion of ligation between this integrin and ¢bronectin
stimulates DNA synthesis [34], whereas increased ex-
pression of the K5L1 integrin may reduce the mito-
genic activity in ¢brosarcoma cell lines [35].
As already mentioned, PXE ¢broblasts, compared
to control cells, have reduced expression of some
integrins (namely L1, K2L1 and K5L1); therefore,
the decreased cell-matrix interactions on synchron-
ized cells could be related to the higher proliferation
capability of PXE cells and could be a consequence
of the PXE gene defect. Although performed on a
limited, but clinically and genetically well de¢ned,
number of patients, these results clearly indicate
that the gene responsible for PXE has to play a
broad regulatory role on mesenchymal cell behavior
and metabolism leading to an unbalanced production
of matrix components. Therefore, elastin and the ex-
tracellular matrix in general would be dramatically
involved only as a ¢nal event. Moreover, elastic ¢-
bers, because of their peculiar physico-chemical
properties and slow turnover, might be a¡ected
more than other components by the alterations of
the extracellular matrix homeostasis in PXE. Fur-
thermore, as for other genetic disorders, dermal ¢-
broblasts may represent a reliable model for investi-
gating on the pathogenesis of connective tissue
genetic disorders, however, since cells from unaf-
fected areas of the same PXE patient behaved in
between control and diseased cells, it may be hy-
pothesized that also local factors may be involved
contributing to the severity of clinical signs in PXE.
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